Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 169

    1.

    Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes.

    Dyck PJ, Davies JL, Clark VM, Litchy WJ, Dyck PJ, Klein CJ, Rizza RA, Pach JM, Klein R, Larson TS, Melton LJ 3rd, O'Brien PC.

    Diabetes Care. 2006 Oct;29(10):2282-8.PMID: 17003307 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes.

    Mäkimattila S, Schlenzka A, Mäntysaari M, Bergholm R, Summanen P, Saar P, Erkkilä H, Yki-Järvinen H.

    Diabetes Care. 2000 Nov;23(11):1686-93.PMID: 11092293 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort.

    Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton LJ 3rd, O'Brien PC.

    Diabetes Care. 1999 Sep;22(9):1479-86.PMID: 10480512 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisited.

    Orchard TJ, Forrest KY, Ellis D, Becker DJ.

    Arch Intern Med. 1997 Sep 8;157(16):1851-6.PMID: 9290544 [PubMed - indexed for MEDLINE]Related articles

    5.

    Glycemic control and the risk of multiple microvascular diabetic complications.

    Schellhase KG, Koepsell TD, Weiss NS.

    Fam Med. 2005 Feb;37(2):125-30.PMID: 15690253 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Reduced tissue oxygenation and its reversibility by glycemic control in diabetic patients.

    Iino K, Yoshinari M, Doi Y, Shinohara N, Iwase M, Fujishima M.

    Diabetes Res Clin Pract. 1997 Jan;34(3):163-8.PMID: 9069568 [PubMed - indexed for MEDLINE]Related articles

    9.

    Estimated benefits of glycemic control in microvascular complications in type 2 diabetes.

    Vijan S, Hofer TP, Hayward RA.

    Ann Intern Med. 1997 Nov 1;127(9):788-95.PMID: 9382399 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Influence of glycemic variables on hemoglobin A1c.

    Service FJ, O'Brien PC.

    Endocr Pract. 2007 Jul-Aug;13(4):350-4.PMID: 17669710 [PubMed - indexed for MEDLINE]Related articles

    11.

    Adequacy of glycemic control in hemodialysis patients with diabetes.

    Tascona DJ, Morton AR, Toffelmire EB, Holland DC, Iliescu EA.

    Diabetes Care. 2006 Oct;29(10):2247-51.PMID: 17003301 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

    Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C.

    JAMA. 2006 Apr 12;295(14):1681-7.PMID: 16609090 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

    Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, Eschwege E; DESIR Study Group.

    Diabetes Care. 2006 Jul;29(7):1619-25.PMID: 16801588 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Type 1 diabetes mellitus in Catalonia: chronic complications and metabolic control ten years after onset.

    Cantón A, Fernández Castańer M, Conget I, Carreras G, Castell C, Tresserras R.

    Med Sci Monit. 2004 May;10(5):CR185-90. Epub 2004 Apr 28.PMID: 15114267 [PubMed - indexed for MEDLINE]Related articles

    15.

    Predictors of glycemic control in Japanese subjects with type 2 diabetes mellitus.

    Tokuyama Y, Ishizuka T, Matsui K, Egashira T, Kanatsuka A.

    Metabolism. 2008 Apr;57(4):453-7.PMID: 18328344 [PubMed - indexed for MEDLINE]Related articles

    16.

    Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus.

    Knutson KL, Ryden AM, Mander BA, Van Cauter E.

    Arch Intern Med. 2006 Sep 18;166(16):1768-74.PMID: 16983057 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Longitudinal assessment of the development of diabetic polyneuropathy and associated risk factors.

    van de Poll-Franse LV, Valk GD, Renders CM, Heine RJ, van Eijk JT.

    Diabet Med. 2002 Sep;19(9):771-6.PMID: 12207815 [PubMed - indexed for MEDLINE]Related articles

    18.

    Hyperglycemia as a major determinant of distal polyneuropathy independent of age and diabetes duration in patients with recently diagnosed diabetes.

    Matsumoto T, Ohashi Y, Yamada N, Kikuchi M.

    Diabetes Res Clin Pract. 1994 Dec 16;26(2):109-13.PMID: 7705191 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisited.

    Lachin JM, Genuth S, Nathan DM, Zinman B, Rutledge BN; DCCT/EDIC Research Group.

    Diabetes. 2008 Apr;57(4):995-1001. Epub 2008 Jan 25.PMID: 18223010 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes: response to Dyck et al.

    Orchard TJ, Costacou T, Miller RG, Prince CT, Pambianco G.

    Diabetes Care. 2007 Feb;30(2):448; author reply 448-9. No abstract available. PMID: 17259536 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data